Market Research Logo

The Worldwide Market for Cancer Diagnostics, 3rd Edition


Attention: There is an updated edition available for this report.

Who are the major players in testing for the number two killer in the world? What revenues can companies competing in this market expect in the next five years? How will the impact of trends such as an increased role of pharmacodiagnostics, the use of multiplex assays and a new emphasis on service products influence cancer diagnostics?

These questions and more are answered in Kalorama Information's Worldwide Market for Cancer Diagnostics, 3rd Edition. This report contains detailed market data on the following areas of cancer diagnostics:

  • Histology/Cytology
  • Immunoassays
  • Flow Cytometry
  • Rapid Tests
  • Molecular Assays
  • Tissue Arrays
  • Circulating Tumor Cells
  • Pharmacodiagnostics
Diagnostic tests for effective cancer screening are obviously needed more than ever. As cancer becomes more treatable, diagnostics are finding multiple expanded roles, including pharmacodiagnostics for matching the targeted treatment to the patient and ongoing disease monitoring as treatable cancer enters the realm of the chronic disease. Kalorama Information's Worldwide Market for Cancer Diagnostics, 3rd Edition represents the third time Kalorama has engaged in an exhaustive study on the status of this important diagnostic market. Among the market data provided in this report, readers will find:
  • Pap Smear Testing Volumes
  • DNA Reagents for Cancer Testing
  • CTC Testing Markets
  • Major Protein and Molecular Markers Used in Tissue Staining
  • Microarray Markets in Clinical Labs
  • Lists of Vendors and Major Products

This report includes detailed market analysis of the following screening tests:

  • DR-70
  • HAAH
  • ECPKA
  • The Cancer Profile
  • CTC
  • Fecal Occult Blood
  • PSA
  • H. pylori
  • IHC
  • ISH
As well as tests for specific cancers:
  • Bladder Cancer
  • Breast Cancer
  • Cervical Cancer
  • Colon Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Prostate Cancer

This latest edition of Kalorama’s study takes a fresh look at all of these developments both qualitatively and quanititatively. The report provides revenue and growth forecasts through 2012 and, as in the previous edition, analyzes the market in two ways:

  • Tests for specific cancers, and
  • Cancer tests in specific IVD segments
This allows the reader to match his or her own situation to the market at large.

In addition to extensive reviews of products on the market and in development in each segment, the report also provides the most extensive review of innovative companies yet compiled in this market with profiles of over 150 companies active in the segment.

Kalorama's diagnostics industry analyst Shara Rosen provides the rigorous analysis and thoughtful research that has been made her market reports the backbone of diagnostic market decision-making for years.

The following companies were profiled in this report:

  • 20/20 GeneSystems Inc.
  • 454 Life Sciences Corporation
  • A&G Pharmaceutical
  • AdnaGen AG
  • Affymetrix Inc.
  • Agendia B.V.
  • Agilent Technologies Inc.
  • Alethia Biotherapeutics Inc.
  • Almac Diagnostics (formerly ArraDx)
  • Althea Technologies, Inc.
  • Ambrilia Biopharma Inc.
  • AMDL, Inc.
  • American Diagnostica Inc.
  • Aperio Technologies, Inc.
  • Applied Genomics, Inc. (AGI)
  • Applied Imaging Corp./Genetix
  • Asuragen, Inc.
  • AsymmetRx, Inc.
  • AviaraDx (formerly Arcturus Biosciences)
  • AVIVA Biosciences Corporation
  • BioCurex, Inc.
  • BioGenex Laboratories, Inc.
  • BioImagene, Inc.
  • Biomoda, Inc.
  • BioMosaics
  • BioNanomatrix
  • Biophysical Corp.
  • BioServe
  • Biosite Incorporated
  • BIOVIEW, Inc.
  • Bostwick Laboratories, Inc.
  • Bruker BioSciences Corporation
  • CCC Diagnostics LLC
  • Cancer Genetics, Inc.
  • Cangen Biotechnologies, Inc.
  • Celera
  • Celerus Diagnostics
  • Cellumen, Inc.
  • CeMines, Inc.
  • ChemSensing
  • Clarient Inc. (formerly ChromaVision)
  • CombiMatrix Molecular Diagnostics (CMDX)
  • CompuCyte Corporation
  • Correlogic Systems, Inc.
  • CytoCore, Inc. (formerly Molecular Diagnostics, Inc.)
  • Cytyc Corporation
  • Dako A/S
  • diaDexus Inc.
  • DiaGenic ASA
  • DiagnoCure
  • Diamics, Inc.
  • Digene Corporation (Acquired by Qiagen)
  • DNA Direct, Inc.
  • DxS
  • eGene Inc.
  • Epigenomics AG
  • EXACT Sciences Corporation
  • eXagen Diagnostics, Inc.
  • Exiqon A/S
  • Falcon Genomics, Inc.
  • Fermiscan Holdings Limited (FER)
  • Fluidigm Corporation
  • Fujirebio Diagnostics. Inc. (FDI)
  • GeneNews Limited (formerly ChondroGene Limited)
  • GenoMed, Inc.
  • Genomic Health
  • Genoptix Inc.
  • Gen-Probe Incorporated
  • Genzyme Corporation
  • Greiner Bio-One International AG
  • Gynecor
  • Health Discovery Corporation
  • HistoRx, Inc,
  • Ikonisys Inc.
  • Illumina
  • ImmunArray Ltd.
  • Immunicon Corporation
  • Immunotope, Inc.
  • InterGenetics, Inc.
  • Invirion Diagnostics, LLC
  • Ipsogen
  • Kronus Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Luminex Corporation
  • MacroArray Technologies, LLC
  • Matritech
  • MDS/Molecular Devices Corporation
  • Med BioGene, Inc. (MBI)
  • Menssana Research, Inc.
  • Micronics Inc.
  • Miraculins Inc.
  • Modern Technology Corp.
  • MolecularMD
  • MonoGen
  • Monogram Biosciences Inc. (formerly Virologic, Inc.)
  • mtm laboratories AG
  • Myriad Genetics, Inc.
  • NeoMatrix, LLC
  • NorChip
  • NorDiag ASA
  • Nuvera Biosciences
  • Olympus Life and Material Science Europa, GMBH
  • Onco Detectors International LLC
  • Oncolab Inc.
  • OncoMethylome Sciences S.A.
  • Onconome, Inc. (formerly Tessera Diagnostics)
  • One Cell Systems, Inc.
  • Orion Genomics
  • Oxford Genome Sciences Ltd. (OGeS)
  • OXIS International
  • Pacific Edge Biotechnology Ltd. (PEB)
  • Panacea Pharmaceuticals, Inc.
  • Pathwork Diagnostics (formerly Predicant Biosciences)
  • Perceptronix Medical Inc.
  • PerkinElmer, Inc.
  • Perlegen Sciences, Inc.
  • PersonaDX
  • Power3 Medical Products, Inc.
  • Precision Therapeutics
  • Predictive Biosciences
  • PreMD Inc.
  • Primagen Holding B.V.
  • Proteome Systems Limited
  • Provista Diagnostics (formerly Biomarker Technologies LLC)
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • RainDance Technologies, Inc. (RDT)
  • Rational Therapeutics
  • Response Genetics, Inc.
  • Rosetta Genomics Ltd.
  • Rubicon Genomics, Inc.
  • Rules-Based Medicine, Inc.
  • Saladax Biomedical, Inc. (SBI)
  • Signet Laboratories, Inc.
  • Source MDx
  • Targeted Diagnostics & Therapeutics, Inc. (TDT)
  • Targeted Molecular Diagnostics, LLC (TDM)
  • Tripath Imaging, Inc.
  • US LABS
  • Ventana Medical Systems. Inc.
  • Veridex, LLC
  • Vermillion, Inc. (formerly Ciphergen Biosystems, Inc.)
  • Vision BioSystems Ltd/Danaher Corp.
  • Vitatex Inc.
  • Wako Chemicals USA
  • WaveSense LLC
  • Xenomics, Inc.
  • Xytos Inc.
  • Zila Inc.

License Note: Kalorama Information's listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.


  • Executive Summary
    • INTRODUCTION
    • SCOPE AND METHODOLOGY
    • SIZE AND GROWTH OF THE MARKET
      • Table Market Summary Worldwide Market for In Vitro Cancer Diagnostics 2004-2009
    • MARKET TRENDS
  • Introduction
    • BACKGROUND
    • CANCER: DIAGNOSIS AND MANAGEMENT OF A CHRONIC DISEASE
    • POINT OF VIEW
  • Trends and Issues in Commercialization
    • BACKGROUND
    • DEMOGRAPHICS OF CANCER, WORLDWIDE
      • Table Major Cancer Incidence Estimates by Cancer Type and Geographic Market Development (More Developed vs Less Developed) 2000
      • Table Worldwide Major Cancer Incidence and Mortality Estimates by Cancer Type, 2000
    • CANCER TESTING IN THE WORLD-SCREENING AND GOVERNMENT SUPPORTED PROGRAMS
      • An Aging World Population
        • Table Old-Age Dependency Ratios Comparative Projections by Leading Country 2000, 2025
      • United States of America
      • Europe
      • People's Republic of China
      • India
      • Canada
    • REIMBURSEMENT AND COMMERCIALIZATION OF NOVEL TESTS
    • CONSUMERISM AND WEB-BASED TEST SERVICES
      • Table Selected DTC Cancer Tests
    • REGULATORY REQUIREMENTS OF NEW PRODUCTS
    • STRATEGIC ALLIANCES-RX-DX AND DX-DX PARTNERSHIPS
      • Table Selected Company Alignments for Cancer Diagnostics, 2005 - 2007
      • Table Selected Agreements Between Companies and Reference Laboratories
      • Table Selected Tests Offered by Company Accredited Laboratories
    • FROM RESEARCH TO THE CLINICAL LAB
      • Table Selected IVDs used in Drug Development
  • Technological Trends Enabling the Future of Cancer Diagnostics
    • BACKGROUND
    • BIOMARKER REVOLUTION
    • THE PROMISE OF PERSONALIZED MEDICINE
      • Table Selected Tumor Markers as Applied to Specific Cancers and Drugs
      • Table Selected Chemotherapy Resistance Tests
    • MINIATURIZATION AND MULTIPLEXED BIOLOGICAL ASSAYS
      • Table Selected Arrays and Biochip Tests for Cancer
    • THE SEARCH FOR NON-INVASIVE TOOLS
      • Table Selected Non-Invasive Cancer Tests (Company, Sample, Test Details, Marketing Status)
      • Serum
      • Saliva
      • Transdermal/Optical
      • Breath
      • Hair
      • Sputum
    • ROLE OF IMMUNOASSAYS IN CANCER MANAGEMENT
    • NEW TECHNOLOGIES APPLIED TO CANCER DIAGNOSTICS
      • Proteomics, Mass Spectroscopy and the Role of the Immune System
      • Methylated Gene (meDNA) Patterns
        • Table Selected Methylated DNA Tests (Company, Technology, Test Details, Marketing Status)
      • Circulating Cell-Free Nucleic Acids
      • RNA-Ribonucleic Acid
        • Table Selected RNA-Based Cancer Tests
      • Stem Cell Markers
    • THE ROLE OF IN VIVO DIAGNOSTICS-IN VIVO CELLULAR AND MOLECULAR IMAGING
  • Market Analysis-In Vitro Tests for Cancer
    • BACKGROUND
    • WORLD SEGMENTS OF THE MARKET FOR CANCER DIAGNOSTICS
      • Table Cancer Demographics: Populations, Cancer Incidence, Share of Incidence, and Share of IVD Cancer Market by Geographic Region 2005
      • Table World Cancer Test Sales by Geographic Region (North America, Europe, Japan, Rest of World) 2007-2012
    • COMPANIES AND PRODUCTS
      • Table Cancer Diagnostics and the Top Tier IVD Companies Segments of Participation 2005
      • Table Revenues of Selected Cancer Diagnostic Companies 2001-2005
      • Screening Tests
      • Cancer Specific Tests
        • Table Selected Breast Cancer Test Innovations
        • Table Selected FOB Test Innovations
        • Table Selected Prostate Cancer Test Innovations (Company, Test Details, Marketing Status)
  • Market Analysis-Cancer tests in IVD Segments
    • CANCER DIAGNOSTICS AND IVD MARKETS
      • Table Worldwide Market for Selected Cancer In Vitro Diagnostics Revenues and Growth Rate by Testing Segment (Histology/Cytology, Immunoassays, Flow Cytometry, Rapid Tests, Molecular Assays, Tissue Arrays, Circulating Tumor Cells, Pharmacodiagnostics) 2007-2012
    • THE MARKET FOR CANCER TESTS IN CLINICAL CHEMISTRY
      • Table Selected Tissue Function Clinical Chemistry Tests
      • Table Major Players For Clinical Chemistry Analyzers And Reagents
    • THE MARKET FOR CANCER TESTS IN IMMUNOASSAYS-LAB-BASED & RAPID
      • Table Lab-Based Cancer Immunoassay Sales 2004-2009
      • Table Potential Cancer Biomarkers
      • Table Selected Cancer Immunoassay Innovations
      • Table Worldwide Rapid Cancer Test Sales by Test Category (Fecal Occult Blood, PSA, H. pylori, NMP22, Other) 2004-2009
    • THE MARKET FOR CANCER TESTS IN HISTOLOGY AND CYTOLOGY
      • Table Worldwide Histology/Cytology Sales by Test Type (Traditional non-Pap, Pap, IHC, ISH) 2004-2009
      • Table Top Vendors of Traditional Histology Stains
      • The Future of the Pap Smear & HPV Testing
        • Table Geographical Distribution of Pap Testing Volume (in millions of tests) by Region (U.S., Europe, Japan, ROW)
        • Table Selected Automated Pap Systems
        • Table Selected HPV test innovators
      • IHC/ISH and Digital Cytometry
        • Table Selected IHC and ISH Product Companies
        • Table Major Protein and Molecular Markers Used in Tissue Staining
        • Table Selected Digital Pathology Systems
      • The Market for Tissue Microarrays
        • Table Selected Laser Microdissection Instruments
      • The Market for Cancer Tests in Flow Cytometry
        • Table Selected Flow Cytometry Innovation (Company, Technology Details, Marketing Status)
      • The Market for Cancer Tests and Image Cytometry
    • THE MARKET FOR CIRCULATING TUMOR CELLS IN CANCER DIAGNOSTICS
      • Table Selected Circulating Tumor Cell Products (Company, Technology, Product Details, Marketing Status)
    • THE MARKET FOR MOLECULAR ASSAYS IN CANCER
      • Table Selected Molecular Tests for Cancer
    • THE MARKET FOR PHARMACODIAGNOSTICS TESTS IN CANCER
      • Table Selected Cancer Pharmacodiagnostic Tests (Company, Test Details, Marketing Status)
    • THE MARKET FOR BIOCHIPS AND ARRAYS IN CANCER DIAGNOSTICS
    • CANCER SAMPLE PREPARATION TECHNIQUES
    • THE COMMERCIAL OUTLOOK FOR CANCER DIAGNOSTICS
  • Conclusions and Strategic Implications
    • CONCLUSIONS
      • Conclusion One
      • Conclusion Two
      • Conclusion Three
      • Conclusion Four
      • Conclusion Five
      • Conclusion Six
    • UNMET MARKET NEEDS
      • Unmet Need One
      • Unmet Need Two
      • Unmet Need Three
  • The Top Tier IVD Companies and Their Investment in Cancer
    • ABBOTT DIAGNOSTICS
      • Recent Revenue History
      • Key Comment
      • Details
    • BECKMAN COULTER, INC.
      • Recent Revenue History
        • Table BECKMAN COULTER, INC. - Total Revenues:
        • Table BECKMAN COULTER, INC. - Immunodiagnostics Revenues (in millions):
        • Table BECKMAN COULTER, INC. - Flow Cytometry Revenues (in millions):
      • Key Comment
      • Details
    • BECTON DICKINSON & COMPANY
      • Recent Revenue History
        • Table BECTON DICKINSON & COMPANY - Flow Cytometry Revenues:
      • Key Comment
      • Details
    • BIOMERIEUX INC.
      • Recent Revenue History
        • Table BIOMERIEUX INC. - Total Revenues (in millions):
        • Table BIOMERIEUX INC. - IVD product revenue in selected test segments (in millions)
      • Key Comment
      • Details
    • BIO-RAD LABORATORIES INC.
      • Key Comment
      • Details
    • INVERNESS MEDICAL INNOVATIONS, INC.
      • Key Comment
      • Details
    • ORTHO CLINICAL DIAGNOSTICS
      • Key Comment
      • Details
    • ROCHE DIAGNOSTICS
      • Key Comment
      • Details
    • SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS
      • Table SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS - Hematology Revenues (in millions):
      • Key Comment
      • Details
    • SYSMEX CORPORATION
      • Table SYSMEX CORPORATION - Hematology Revenues (in millions):
      • Key Comment
      • Details
  • New Entrants and Novel Product Developers
    • 20/20GENESYSTEMS INC.
    • 454 LIFE SCIENCES CORPORATION
    • A&G PHARMACEUTICAL
    • ADNAGEN AG
    • AFFYMETRIX INC.
    • AGENDIA B.V.
    • AGILENT TECHNOLOGIES INC.
    • ALETHIA BIOTHERAPEUTICS INC.
    • ALMAC DIAGNOSTICS (FORMERLY ARRADX)
    • ALTHEA TECHNOLOGIES, INC.
    • AMBRILIA BIOPHARMA INC.
    • AMDL, INC.
      • Table AMDL, INC. - Recent Revenue History
    • AMERICAN DIAGNOSTICA INC.
    • APERIO TECHNOLOGIES, INC.
    • APPLIED GENOMICS, INC. (AGI)
    • APPLIED IMAGING CORP./GENETIX
    • ASURAGEN, INC.
    • ASYMMETRX, INC.
    • AVIARADX (FORMERLY ARCTURUS BIOSCIENCES)
    • AVIVA BIOSCIENCES CORPORATION
    • BIOCUREX, INC.
    • BIOGENEX LABORATORIES, INC.
    • BIOIMAGENE, INC.
    • BIOMODA, INC.
    • BIOMOSAICS
    • BIONANOMATRIX
    • BIOPHYSICAL CORP.
    • BIOSERVE
    • BIOSITE INCORPORATED
      • Table BIOSITE INCORPORATED - Recent Revenue History (in millions)
    • BIOVIEW, INC.
    • BOSTWICK LABORATORIES, INC.
    • BRUKER BIOSCIENCES CORPORATION
    • CCC DIAGNOSTICS LLC
    • CANCER GENETICS, INC.
    • CANGEN BIOTECHNOLOGIES, INC.
    • CELERA
    • CELERUS DIAGNOSTICS
    • CELLUMEN, INC.
    • CEMINES, INC.
    • CHEMSENSING
    • CLARIENT INC. (FORMERLY CHROMAVISION)
    • COMBIMATRIX MOLECULAR DIAGNOSTICS (CMDX)
    • COMPUCYTE CORPORATION
    • CORRELOGIC SYSTEMS, INC.
    • CYTOCORE, INC. (FORMERLY MOLECULAR DIAGNOSTICS, INC.)
    • CYTYC CORPORATION
      • Table CYTYC CORPORATION - Recent Revenue History*:
    • DAKO A/S
      • Table DAKO A/S - Recent Revenue History:
    • DIADEXUS INC.
    • DIAGENIC ASA
    • DIAGNOCURE
      • Table DIAGNOCURE - Recent Revenue History
    • DIAMICS, INC.
    • DIGENE CORPORATION (ACQUIRED BY QIAGEN)
      • Table DIGENE CORPORATION (ACQUIRED BY QIAGEN) - Recent Revenue History:
    • DNA DIRECT, INC.
    • DXS
    • EGENE INC.
    • EPIGENOMICS AG
    • EXACT SCIENCES CORPORATION
    • EXAGEN DIAGNOSTICS, INC.
    • EXIQON A/S
    • FALCON GENOMICS, INC.
    • FERMISCAN HOLDINGS LIMITED (FER)
    • FLUIDIGM CORPORATION
    • FUJIREBIO DIAGNOSTICS. INC. (FDI)
      • Table FUJIREBIO DIAGNOSTICS. INC. (FDI) - Recent Revenue History:
    • GENENEWS LIMITED (FORMERLY CHONDROGENE LIMITED)
    • GENOMED, INC.
    • GENOMIC HEALTH
      • Table GENOMIC HEALTH - Recent Revenue History:
    • GENOPTIX INC.
    • GEN-PROBE INCORPORATED
    • GENZYME CORPORATION
      • Table GENZYME CORPORATION - Recent Revenue History:
    • GREINER BIO-ONE INTERNATIONAL AG
      • Table GREINER BIO-ONE INTERNATIONAL AG - Recent Revenue History:
    • GYNECOR
    • HEALTH DISCOVERY CORPORATION
    • HISTORX, INC,
    • IKONISYS INC.
    • ILLUMINA
    • IMMUNARRAY LTD.
    • IMMUNICON CORPORATION
      • Table IMMUNICON CORPORATION - Recent Revenue History:
    • IMMUNOTOPE, INC.
    • INTERGENETICS, INC.
    • INVIRION DIAGNOSTICS, LLC
    • IPSOGEN
    • KRONUS INC.
    • LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
    • LUMINEX CORPORATION
    • MACROARRAY TECHNOLOGIES, LLC
    • MATRITECH
      • Table MATRITECH - Recent Revenue History:
    • MDS/MOLECULAR DEVICES CORPORATION
    • MED BIOGENE, INC. (MBI)
    • MENSSANA RESEARCH, INC.
    • MICRONICS INC.
    • MIRACULINS INC.
    • MODERN TECHNOLOGY CORP.
    • MOLECULARMD
    • MONOGEN
    • MONOGRAM BIOSCIENCES INC. (FORMERLY VIROLOGIC, INC.)
      • Table MONOGRAM BIOSCIENCES INC. (FORMERLY VIROLOGIC, INC.) - Recent Revenue History:
    • MTM LABORATORIES AG
    • MYRIAD GENETICS, INC.
      • Table MYRIAD GENETICS, INC. - Recent Revenue History:
    • NEOMATRIX, LLC
    • NORCHIP
    • NORDIAG ASA
    • NUVERA BIOSCIENCES
    • OLYMPUS LIFE AND MATERIAL SCIENCE EUROPA, GMBH
    • ONCO DETECTORS INTERNATIONAL LLC
    • ONCOLAB INC.
    • ONCOMETHYLOME SCIENCES S.A.
    • ONCONOME, INC. (FORMERLY TESSERA DIAGNOSTICS)
    • ONE CELL SYSTEMS, INC.
    • ORION GENOMICS
    • OXFORD GENOME SCIENCES LTD. (OGES)
    • OXIS INTERNATIONAL
    • PACIFIC EDGE BIOTECHNOLOGY LTD. (PEB)
    • PANACEA PHARMACEUTICALS, INC.
    • PATHWORK DIAGNOSTICS (FORMERLY PREDICANT BIOSCIENCES)
    • PERCEPTRONIX MEDICAL INC.
    • PERKINELMER, INC.
    • PERLEGEN SCIENCES, INC.
    • PERSONADX
    • POWER3 MEDICAL PRODUCTS, INC.
    • PRECISION THERAPEUTICS
    • PREDICTIVE BIOSCIENCES
    • PREMD INC.
    • PRIMAGEN HOLDING B.V.
    • PROTEOME SYSTEMS LIMITED
    • PROVISTA DIAGNOSTICS (FORMERLY BIOMARKER TECHNOLOGIES LLC)
    • QIAGEN N.V.
      • Table QIAGEN N.V. - Recent Revenue History: (in millions)
    • QUEST DIAGNOSTICS INCORPORATED
    • RAINDANCE TECHNOLOGIES, INC. (RDT)
    • RATIONAL THERAPEUTICS
    • RESPONSE GENETICS, INC.
      • Table RESPONSE GENETICS, INC. - Recent Revenue History:
    • ROSETTA GENOMICS LTD.
    • RUBICON GENOMICS, INC.
    • RULES-BASED MEDICINE, INC.
    • SALADAX BIOMEDICAL, INC. (SBI)
    • SIGNET LABORATORIES, INC.
    • SOURCE MDX
    • TARGETED DIAGNOSTICS & THERAPEUTICS, INC. (TDT)
    • TARGETED MOLECULAR DIAGNOSTICS, LLC (TDM)
    • TRIPATH IMAGING, INC.
      • Table TRIPATH IMAGING, INC. - Recent Revenue History:
    • US LABS
    • VENTANA MEDICAL SYSTEMS. INC.
      • Table VENTANA MEDICAL SYSTEMS. INC. - Recent Revenue History: $ million
    • VERIDEX, LLC
    • VERMILLION, INC. (FORMERLY CIPHERGEN BIOSYSTEMS, INC.)
    • VISION BIOSYSTEMS LTD/DANAHER CORP.
      • Table VISION BIOSYSTEMS LTD/DANAHER CORP. - Recent Revenue History
    • VITATEX INC.
    • WAKO CHEMICALS USA
    • WAV E SENSE LLC
    • XENOMICS, INC.
    • XYTOS INC.
    • ZILA INC.
  • Selected Cancer Tests on the Market and In Development
    • Table Selected Cancer Tests on the Market and In Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report